Valproate Drug Safety Update
Published: 20/02/25
New resources have been developed to support healthcare professionals in the management of Valproate prescribing.
Valproate (as sodium valproate, valproic acid or valproate semisodium) is authorised for the treatment of epilepsy and bipolar disorder. Valproate is known to have potential risks of major congenital malformations or neurodevelopmental disorders in children when mothers take valproate during pregnancy. More recently, the risk of a range of neurodevelopmental disorders in children born to fathers taking valproate compared to other antiseizures medicines has been described.
Recent review and updated advice
Review by two specialists remains in place for all patients initiating valproate under 55 years of age but the Commission on Human Medicines (CHM) has advised that it will not be required for men (or males) currently taking valproate.
The information considered by CHM and the advice issued is presented in a Public Assessment Report.
Advice for Healthcare Professionals to Provide to Patients:
do not stop taking valproate without advice from a specialist. This is because epilepsy or bipolar disorder may worsen without treatment
if you are on valproate, please attend any offered appointments to discuss your treatment and talk to a healthcare professional if you are concerned
if you wish to discuss family planning, please contact a healthcare professional.
The CHM noted that there is now a recommendation in place that male patients and their female partners should use effective contraception while taking valproate and for 3 months after stopping. Men will be made aware of the need to use contraception by information on the patient card provided when valproate is dispensed and that if they are planning a family, to discuss with their GP the need to be referred to a specialist to discuss other treatment options.
The drug safety update, along with the three resources are available by clicking the links below:
Congratulations again on your recent qualification, and the start of your career as a registered Pharmacist!
The SPPN newsletter is a useful way for pharmacy teams to keep up with what is happening across the pain network
Community Pharmacy Scotland is supporting to promote an upcoming webinar from colleagues at Public Services Delivery Scotland.
This week’s MCR Ready Reckoner has been updated and is now available to download or you can view it via the App.
With just over three weeks to go, CPS thanks Charity Golf Day sponsors and encourages final team entries to support Blood Bikes Scotland.
A weekly snapshot of CPS activity including policy work, digital developments and stakeholder engagement across community pharmacy.
Pharmacy Manager opportunity with Lindsay & Gilmour in Craigmillar, leading NHS services, supporting patients and developing pharmacy teams.
Pharmacist Manager opportunity at Willow Pharmacy in Dunfermline. Lead a community pharmacy team and help develop NHS clinical services.
The Serious Shortage Protocol for Creon® 10000 has been extended until 2 October 2026. Review the updated SSP arrangements.
Community Pharmacy Scotland is keen to showcase examples of how pharmacy teams are helping to reduce medicines waste across Scotland as part of work we involved in nationally.
Disclosure Scotland has published its June 2026 newsletter, covering two important updates for PVG scheme members and customers.
A weekly snapshot of CPS activity including policy work, digital developments and stakeholder engagement across community pharmacy.
The Yellow Card Scheme in the UK is a system for collecting and monitoring information about suspected adverse drug reactions and safety concerns related to medicines and medical devices.
We have run a short series of articles on the NHS PFS Service over recent weeks, focussing on some specific aspects of the service.
Pharmacy First Scotland refresher: join our live AMA on Thursday 20th August, 19:30–21:00 on Microsoft Teams. Bring your questions
Lead a community pharmacy in Drymen with Davidsons Chemists, developing services, supporting patients and growing your career.
Lead Davidsons Chemists' flagship Blairgowrie pharmacy as an Independent Prescribing Pharmacist and help shape future clinical services.
Join Davidsons Chemists as Pharmacist Manager in Montrose. Supportive environment, strong development pathways and excellent benefits. Apply by 31st October 2026.
One item has been removed from Part 7B of the Scottish Drug Tariff from 1st August 2026. Read the latest update.
An update on August 2026 Part 7 publishing timelines following early finalisation of February adjusted prices. Key dates explained.
Pharmacist Manager opportunity in Peebles with leadership autonomy, Independent Prescriber support and opportunities to develop private services.
Download the prescription collection dates for July to December 2026 and find guidance on courier collections, bags and support.
Independent Prescribing Pharmacist role in Dundee with flexible hours, no management responsibilities and opportunities to develop NHS and private services.
Five weeks to go until the CPS Charity Golf Day 2026. Enter a team, sponsor the event, donate a raffle prize or support Blood Bikes Scotland.
This week, CPS Policy and Development Pharmacist Gordon Winter joined BBC Radio Scotland’s Drivetime programme to discuss what the data means for community pharmacy and the wider primary care landscape.
Six years of NHS Pharmacy First Scotland, with more than 1.9 million people using the service and continued expansion of independent prescribing.
A national workforce survey will take place in September 2026 to support community pharmacy workforce planning across Scotland.
Join Omnicare Pharmacy in Fife as a Pharmacy Manager. Competitive salary, great benefits, and career development. Apply by 31st August 2026.

Full-time dispenser opportunity in Glasgow with responsibilities for administration and assistant management. No weekend working.